Home Cart 0 Sign in  
X

[ CAS No. 29518-11-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 29518-11-4
Chemical Structure| 29518-11-4
Chemical Structure| 29518-11-4
Structure of 29518-11-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 29518-11-4 ]

Related Doc. of [ 29518-11-4 ]

Alternatived Products of [ 29518-11-4 ]

Product Details of [ 29518-11-4 ]

CAS No. :29518-11-4 MDL No. :MFCD00624822
Formula : C10H11NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :SIWXCJHUZAEIAE-UHFFFAOYSA-N
M.W : 177.20 Pubchem ID :5153080
Synonyms :

Calculated chemistry of [ 29518-11-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 52.37
TPSA : 29.54 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.9
Log Po/w (XLOGP3) : 0.94
Log Po/w (WLOGP) : 0.67
Log Po/w (MLOGP) : 0.88
Log Po/w (SILICOS-IT) : 1.66
Consensus Log Po/w : 1.21

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.81
Solubility : 2.77 mg/ml ; 0.0156 mol/l
Class : Very soluble
Log S (Ali) : -1.15
Solubility : 12.6 mg/ml ; 0.0713 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.47
Solubility : 0.602 mg/ml ; 0.0034 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.49

Safety of [ 29518-11-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 29518-11-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 29518-11-4 ]
  • Downstream synthetic route of [ 29518-11-4 ]

[ 29518-11-4 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 105-39-5 ]
  • [ 122-98-5 ]
  • [ 29518-11-4 ]
YieldReaction ConditionsOperation in experiment
83% With potassium <i>tert</i>-butylate In tetrahydrofuran at 38℃; for 16 h; Inert atmosphere 1 g of phenylaminoethanol and 0.834 g of potassium t-butoxide were placed in a three-necked flask.Then add 10 mL of anhydrous tetrahydrofuran as a solvent under the protection of nitrogen.The oil bath is fully stirred and dissolved, and the oil bath temperature is 38 ° C.Then add 1 mL of ethyl chloroacetate.The reaction was continued for 16 h to give 4-phenyl-3-morpholinone.After the reaction, the solvent tetrahydrofuran was first spun out using a rotary evaporator.Then add a small amount of ethyl acetate for extraction and separation.The organic phases were combined, dried over anhydrous sodium sulfate and distilled under reduced pressure.After separation by column chromatography,Recrystallization from petroleum ether gave 4-phenyl-3-morpholinone.The yield was 83percent.
Reference: [1] Patent: CN104788444, 2018, B, . Location in patent: Paragraph 0035; 0036; 0037
[2] Heterocycles, 2007, vol. 74, # C, p. 437 - 445
  • 2
  • [ 79-04-9 ]
  • [ 122-98-5 ]
  • [ 29518-11-4 ]
YieldReaction ConditionsOperation in experiment
89% With sodium hydroxide In ethanol; water at 0 - 38℃; for 2 h; A500 mL flask was charged with 2-anilinoethanol (27.4 g, 180.1 mmol), 30 mLEtOH, an overhead stirrer, a calibrated pH probe, and 100 ml water. An additionfunnel was charged with 10 N sodium hydroxide solution (120 ml, 120.0 mmol).The solution was heated to 38 °C, and treated with chloracetyl chloride (47.7ml, 600.0 mmol) via a syringe pump over 1 h. The sodium hydroxide solution wassimultaneously added to the stirring solution so that the pH was maintainedbetween 12 and 12.5. After the addition was complete, the solution was cooledto 0 °C and stirred for 1 h. The solids were collected and washed with coldwate (2 × 60 mL). The solids were dried at 50 0C at 0.2 mm Hg for 36 h toafford 5 (28.4 g, 89.0 percent).1HNMR (300 MHz, CDCl3): δ 3.08 (t,J = 5.1 Hz, 2H), 3.96 (t, J = 5.1Hz, 2H), 4.27 (s, 2H), 7.09-7.21 (m, 5H).
68% With sodium hydroxide In ethanol; water at 38 - 45℃; for 0.5 h; Industry scale In a 5L four-necked flask, water (3L), ethanol (IL) and 2-(phenylamino) ethanol (lkg , 7.300mol) were heated to 38 0C while stirring. Chloroacetyl chloride ( 2.47kg , 3eq ) and 45percent sodium hydroxide solution (NaOH 1.9kg/H2O 3.1 1, β.2eq) were then added simultaneously at temperature of 38-45 0C within 60 to 80 minutes; pH 10 to 13; and stirred at this temperature for 30 minutes. It was further cooled to 8 0C and stirred at this temperature for another 30 minutes. The precipitated product was filtered off and washed twice with 2.5kg water, each time of demineralised water at 2 0C. The moist product is dried to constant mass at 50 0C under reduced pressure to obtain 1.4kg of product (Yield 68percent).
62% With sodium hydroxide In isopropyl alcohol at 0 - 40℃; Example 1: Preparation of 4-phenylmorpholin-3-one To a solution of 2-anilino ethanol (6.0 mL, 47.8 mmol) in IPA (6 mL) heated to 40 °C were simultaneously added dropwise chloroacetyl chloride (11.4 mL, 143.4 mmol) and 10 N NaOH (29.6 mL, 296 mmol) maintaining the pH around 7-8. After the addition, the mixture was stirred at 40 °C for 10 min, was cooled to 0 °C and was stirred at this temperature for 1 h. The white solid formed was collected by filtration, washed with cold water and dried, affording 4- phenylmorpholin-3-one (5.27 g, 62percent) as a white solid. 1H NMR (400 MHz, CDCI3) δ 7.42 (t, J = 8.0 Hz, 2 H), 7.34-7.27 (m, 3 H), 4.35 (s, 2 H). 4.04 (t, J = 5.2 Hz, 2 H), 3.77 (t, J = 5.2 Hz, 2 H).
62.5% With sodium hydroxide In ethanol; water at 0 - 41℃; for 2 h; A 250-mL flask was charged with 2-anilinoethanol (9.17 ml, 73.2 mmol), 9 mL dry EtOH, an overhead stirrer, a calibrated pH probe, and 27 niL water. An addition funnel was charged with 10 N sodium hydroxide solution (45.4 ml, 454 mmol). The solution was heated to 41 °C, and treated with chloracetyl chloride (17.5 ml, 220 mmol) via a syringe pump over 1 h. The sodium hydroxide solution was simultaneously added to the stirring solution so that the pH was maintained between 12 and 12.5. After the addition was complete, the solution was cooled to 0 °C and stirred for 1 h. The solids were collected and washed with water (2 X 60 mL cold water). The solids were dried at 50 0C at 0.2 mm Hg for 36 h to afford 4-phenylmorpholin-3-one (8.10 g, 62.5percent yield). 1H NMR (400 MHz, CHLOROFORM-d) 3.75 - 3.80 (m, 2 H) 4.02 - 4.06 (m, 2 H) 4.35 (s, 2 H) 7.27 - 7.36 (m, 3 H) 7.39 - 7.46 (m, 2 H). 13C NMR (101 MHz, CHLOROFORM-d) 49.69 (s, 1 C) 64.14 (s, 1 C) 68.57 (s, 1 C) 125.48 (s, 2 C) 127.15 (s, 1 C) 129.30 (s, 2 C) 141.31 (s, 1 C) 166.59 (s, 1 C).

Reference: [1] European Journal of Medicinal Chemistry, 2015, vol. 95, p. 388 - 399
[2] Patent: WO2005/26135, 2005, A1, . Location in patent: Page/Page column 6
[3] Patent: WO2011/12321, 2011, A1, . Location in patent: Page/Page column 30
[4] Helvetica Chimica Acta, 2013, vol. 96, # 11, p. 2160 - 2172
[5] Patent: WO2011/80341, 2011, A1, . Location in patent: Page/Page column 14; 15
[6] Patent: WO2006/116713, 2006, A1, . Location in patent: Page/Page column 209-210; 213-214
[7] Patent: US2007/66611, 2007, A1,
[8] Journal of Chemical Research, 2011, vol. 35, # 7, p. 400 - 401
[9] Patent: WO2013/98833, 2013, A2, . Location in patent: Page/Page column 35-36
[10] Patent: US2014/378682, 2014, A1, . Location in patent: Paragraph 0186; 0187
  • 3
  • [ 92-53-5 ]
  • [ 29518-11-4 ]
  • [ 13238-43-2 ]
YieldReaction ConditionsOperation in experiment
46% With ozone In acetonitrile at 25℃; for 24 h; Ozone was bubbled for 15 min in 1 L of the appropriate solvent at the selected temperature. The content of ozone was measured by iodometric titration.35N-Phenylmorpholine 1 in the amount for the appropriate stoichiometry with ozone was then added to the solution. After 24 h reaction, the suspension was filtered, evaporated at reduced pressure, and the residue was separated by flash chromatography over silica gel (R=100) eluting with the mixture dichloromethane/ethyl acetate 9:1.4.3.1. N-Phenylmorpholinone (2)White powder: IR (CaF2): 1655 cm-1; MS: m/z=177 (M+), 148 (M+-CHO), 119 (M+-2CHO), 101 (M+-2CHO-CH3); 1H NMR (400 MHz, CDCl3): δ 3.07 (t, J=5.1 Hz, 2H), 3.97 (t, J=5.1 Hz, 2H), 4.28 (s, 2H), 7.10-7.20 (m, 5H); 13C NMR (100 MHz, CDCl3): δ 161.0, 129.0, 126.5, 124.0, 60.0, 43.5, 28.5.4.3.2. Compound 3Yellow oil: IR (CaF2): 1725, 1675 cm-1; MS: m/z=193 (M+), 165 (M+-CO), 147 (M+-HCOOH), 134 (M+-CO-CHO); 1H NMR (400 MHz, CDCl3): δ 4.03 (t, J=5.1 Hz, 2H), 4.27 (t, J=5.1 Hz, 2H), 7.05-7.40 (m, 5H), 7.91 (s, 1H), 8.34 (s, 1H); 13C NMR (100 MHz, CDCl3): δ 161.0, 160.0, 141.0, 130.0, 126.5, 124.7, 60.3, 44.1.
Reference: [1] Tetrahedron, 2012, vol. 68, # 39, p. 8267 - 8275
  • 4
  • [ 92-53-5 ]
  • [ 29518-11-4 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2000, vol. 37, # 1, p. 109 - 110
  • 5
  • [ 62-53-3 ]
  • [ 29518-11-4 ]
Reference: [1] Patent: CN103804221, 2016, B,
[2] Patent: CN103804221, 2016, B,
[3] Patent: CN103804221, 2016, B,
[4] Patent: CN103804221, 2016, B,
[5] Patent: CN104788444, 2018, B,
  • 6
  • [ 103-84-4 ]
  • [ 29518-11-4 ]
Reference: [1] Patent: CN103804221, 2016, B,
  • 7
  • [ 100-01-6 ]
  • [ 29518-11-4 ]
Reference: [1] Patent: CN103804221, 2016, B,
  • 8
  • [ 29518-11-4 ]
  • [ 446292-07-5 ]
Reference: [1] Patent: WO2011/12321, 2011, A1,
[2] Patent: WO2013/98833, 2013, A2,
[3] Patent: US2014/378682, 2014, A1,
  • 9
  • [ 29518-11-4 ]
  • [ 446292-08-6 ]
Reference: [1] Patent: WO2011/12321, 2011, A1,
[2] Patent: WO2013/98833, 2013, A2,
[3] Patent: WO2013/98833, 2013, A2,
[4] Patent: US2014/378682, 2014, A1,
[5] Patent: US2014/378682, 2014, A1,
  • 10
  • [ 29518-11-4 ]
  • [ 721401-53-2 ]
Reference: [1] Patent: CN104788444, 2018, B,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 29518-11-4 ]

Rivaroxaban Related Intermediates

Chemical Structure| 161596-47-0

[ 161596-47-0 ]

(S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione

Chemical Structure| 446292-07-5

[ 446292-07-5 ]

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione

Chemical Structure| 721401-53-2

[ 721401-53-2 ]

(R)-5-Chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Chemical Structure| 446292-08-6

[ 446292-08-6 ]

(S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione

Related Functional Groups of
[ 29518-11-4 ]

Aryls

Chemical Structure| 446292-04-2

[ 446292-04-2 ]

4-(4-Nitrophenyl)morpholin-3-one

Similarity: 0.79

Chemical Structure| 2524-67-6

[ 2524-67-6 ]

4-Morpholinoaniline

Similarity: 0.78

Chemical Structure| 92-53-5

[ 92-53-5 ]

4-Phenylmorpholine

Similarity: 0.78

Chemical Structure| 159724-40-0

[ 159724-40-0 ]

3-(4-Morpholinyl)aniline

Similarity: 0.76

Chemical Structure| 579-10-2

[ 579-10-2 ]

N-Methylacetanilide

Similarity: 0.76

Amides

Chemical Structure| 446292-04-2

[ 446292-04-2 ]

4-(4-Nitrophenyl)morpholin-3-one

Similarity: 0.79

Chemical Structure| 579-10-2

[ 579-10-2 ]

N-Methylacetanilide

Similarity: 0.76

Chemical Structure| 1249057-53-1

[ 1249057-53-1 ]

3-Amino-1-(2-methoxyethyl)pyridin-2(1H)-one

Similarity: 0.75

Chemical Structure| 1267610-26-3

[ 1267610-26-3 ]

1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one

Similarity: 0.73

Chemical Structure| 13143-47-0

[ 13143-47-0 ]

1-(4-Aminophenyl)-1H-pyridin-2-one

Similarity: 0.71

Related Parent Nucleus of
[ 29518-11-4 ]

Aliphatic Heterocycles

Chemical Structure| 446292-04-2

[ 446292-04-2 ]

4-(4-Nitrophenyl)morpholin-3-one

Similarity: 0.79

Chemical Structure| 2524-67-6

[ 2524-67-6 ]

4-Morpholinoaniline

Similarity: 0.78

Chemical Structure| 159724-40-0

[ 159724-40-0 ]

3-(4-Morpholinyl)aniline

Similarity: 0.76

Chemical Structure| 446292-10-0

[ 446292-10-0 ]

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one

Similarity: 0.71

Chemical Structure| 1204-86-0

[ 1204-86-0 ]

4-Morpholinobenzaldehyde

Similarity: 0.71

Morpholines

Chemical Structure| 446292-04-2

[ 446292-04-2 ]

4-(4-Nitrophenyl)morpholin-3-one

Similarity: 0.79

Chemical Structure| 2524-67-6

[ 2524-67-6 ]

4-Morpholinoaniline

Similarity: 0.78

Chemical Structure| 92-53-5

[ 92-53-5 ]

4-Phenylmorpholine

Similarity: 0.78

Chemical Structure| 159724-40-0

[ 159724-40-0 ]

3-(4-Morpholinyl)aniline

Similarity: 0.76

Chemical Structure| 1267610-26-3

[ 1267610-26-3 ]

1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one

Similarity: 0.73